<?xml version="1.0"?>
<rss version="2.0">
 <channel>
  <title>StreetInsider.com News Articles</title>
  <link>http://new.streetinsider.com</link>
  <description>Latest StreetInsider.com News Articles</description>
  <language>en-us</language>
  <copyright>Copyright 2026, StreetInsider.com</copyright>
  <managingEditor>rss@streetinsider.com (SI RSS)</managingEditor>
  <webMaster>rss@streetinsider.com (SI RSS)</webMaster>
  <lastBuildDate>Mon, 15 Jun 2026 06:00:00 -0400</lastBuildDate>
  <docs>http://blogs.law.harvard.edu/tech/rss</docs>
  <image>
   <url>http://www.streetinsider.com/images/rss_logo.gif</url>
   <title>StreetInsider.com News Articles</title>
   <link>http://new.streetinsider.com</link>
   <width>143</width>
   <height>28</height>
  </image>
  <skipHours>
   <hour>0</hour>
   <hour>1</hour>
   <hour>2</hour>
   <hour>3</hour>
   <hour>21</hour>
   <hour>22</hour>
   <hour>23</hour>
  </skipHours>
  <skipDays>
   <day>Saturday</day>
   <day>Sunday</day>
  </skipDays>
  <item>
   <title>Fennec Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)</title>
   <link>http://www.streetinsider.com/Press+Releases/Fennec+Pharmaceuticals+Announces+Inducement+Grants+Under+Nasdaq+Listing+Rule+5635%28C%29%284%29/26643470.html</link>
   <description>
&lt;p align=&quot;justify&quot;&gt;RESEARCH TRIANGLE PARK, N.C., June  15, 2026  (GLOBE NEWSWIRE) -- Fennec Pharmaceuticals Inc. (NASDAQ:FENC) (TSX:FRX) (“Fennec” or the “Company”), a specialty pharmaceutical company, today announced that on June 10, 2026, the Compensation Committee of the Company’s Board of Directors approved the grant of incentive stock option awards (“ISOs”) to purchase an aggregate of 10,000 of the Company’s common shares to one new non-executive employee of the Company with a grant date of June 15, 2026 under the Company’s 2026 Equity Inducement Plan (the “Inducement Plan”). The ISOs were granted as inducements material to the employee entering into</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Fennec+Pharmaceuticals+Announces+Inducement+Grants+Under+Nasdaq+Listing+Rule+5635%28C%29%284%29/26643470.html</guid>
   <pubDate>Mon, 15 Jun 2026 06:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">FENC</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">FRX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.21047090</category>
   	  </item>
  <item>
   <title>Fennec Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)</title>
   <link>http://www.streetinsider.com/Press+Releases/Fennec+Pharmaceuticals+Announces+Inducement+Grants+Under+Nasdaq+Listing+Rule+5635%28C%29%284%29/26643470.html</link>
   <description>
&lt;p align=&quot;justify&quot;&gt;RESEARCH TRIANGLE PARK, N.C., June  15, 2026  (GLOBE NEWSWIRE) -- Fennec Pharmaceuticals Inc. (NASDAQ:FENC) (TSX:FRX) (“Fennec” or the “Company”), a specialty pharmaceutical company, today announced that on June 10, 2026, the Compensation Committee of the Company’s Board of Directors approved the grant of incentive stock option awards (“ISOs”) to purchase an aggregate of 10,000 of the Company’s common shares to one new non-executive employee of the Company with a grant date of June 15, 2026 under the Company’s 2026 Equity Inducement Plan (the “Inducement Plan”). The ISOs were granted as inducements material to the employee entering into</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Fennec+Pharmaceuticals+Announces+Inducement+Grants+Under+Nasdaq+Listing+Rule+5635%28C%29%284%29/26643470.html</guid>
   <pubDate>Mon, 15 Jun 2026 06:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">FENC</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">FRX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.21047090</category>
   	  </item>
  <item>
   <title>Fennec Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)</title>
   <link>http://www.streetinsider.com/Press+Releases/Fennec+Pharmaceuticals+Announces+Inducement+Grants+Under+Nasdaq+Listing+Rule+5635%28C%29%284%29/26643470.html</link>
   <description>
&lt;p align=&quot;justify&quot;&gt;RESEARCH TRIANGLE PARK, N.C., June  15, 2026  (GLOBE NEWSWIRE) -- Fennec Pharmaceuticals Inc. (NASDAQ:FENC) (TSX:FRX) (“Fennec” or the “Company”), a specialty pharmaceutical company, today announced that on June 10, 2026, the Compensation Committee of the Company’s Board of Directors approved the grant of incentive stock option awards (“ISOs”) to purchase an aggregate of 10,000 of the Company’s common shares to one new non-executive employee of the Company with a grant date of June 15, 2026 under the Company’s 2026 Equity Inducement Plan (the “Inducement Plan”). The ISOs were granted as inducements material to the employee entering into</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Fennec+Pharmaceuticals+Announces+Inducement+Grants+Under+Nasdaq+Listing+Rule+5635%28C%29%284%29/26643470.html</guid>
   <pubDate>Mon, 15 Jun 2026 06:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">FENC</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">FRX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.21047090</category>
   	  </item>
  <item>
   <title>Fennec Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)</title>
   <link>http://www.streetinsider.com/Globe+Newswire/Fennec+Pharmaceuticals+Announces+Inducement+Grants+Under+Nasdaq+Listing+Rule+5635%28C%29%284%29/26643470.html</link>
   <description>
&lt;p align=&quot;justify&quot;&gt;RESEARCH TRIANGLE PARK, N.C., June  15, 2026  (GLOBE NEWSWIRE) -- Fennec Pharmaceuticals Inc. (NASDAQ:FENC) (TSX:FRX) (“Fennec” or the “Company”), a specialty pharmaceutical company, today announced that on June 10, 2026, the Compensation Committee of the Company’s Board of Directors approved the grant of incentive stock option awards (“ISOs”) to purchase an aggregate of 10,000 of the Company’s common shares to one new non-executive employee of the Company with a grant date of June 15, 2026 under the Company’s 2026 Equity Inducement Plan (the “Inducement Plan”). The ISOs were granted as inducements material to the employee entering into</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/Fennec+Pharmaceuticals+Announces+Inducement+Grants+Under+Nasdaq+Listing+Rule+5635%28C%29%284%29/26643470.html</guid>
   <pubDate>Mon, 15 Jun 2026 06:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">FENC</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">FRX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.21047090</category>
   	  </item>
  <item>
   <title>Fennec Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)</title>
   <link>http://www.streetinsider.com/Globe+Newswire/Fennec+Pharmaceuticals+Announces+Inducement+Grants+Under+Nasdaq+Listing+Rule+5635%28C%29%284%29/26643470.html</link>
   <description>
&lt;p align=&quot;justify&quot;&gt;RESEARCH TRIANGLE PARK, N.C., June  15, 2026  (GLOBE NEWSWIRE) -- Fennec Pharmaceuticals Inc. (NASDAQ:FENC) (TSX:FRX) (“Fennec” or the “Company”), a specialty pharmaceutical company, today announced that on June 10, 2026, the Compensation Committee of the Company’s Board of Directors approved the grant of incentive stock option awards (“ISOs”) to purchase an aggregate of 10,000 of the Company’s common shares to one new non-executive employee of the Company with a grant date of June 15, 2026 under the Company’s 2026 Equity Inducement Plan (the “Inducement Plan”). The ISOs were granted as inducements material to the employee entering into</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/Fennec+Pharmaceuticals+Announces+Inducement+Grants+Under+Nasdaq+Listing+Rule+5635%28C%29%284%29/26643470.html</guid>
   <pubDate>Mon, 15 Jun 2026 06:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">FENC</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">FRX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.21047090</category>
   	  </item>
  <item>
   <title>Fennec Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)</title>
   <link>http://www.streetinsider.com/Globe+Newswire/Fennec+Pharmaceuticals+Announces+Inducement+Grants+Under+Nasdaq+Listing+Rule+5635%28C%29%284%29/26643470.html</link>
   <description>
&lt;p align=&quot;justify&quot;&gt;RESEARCH TRIANGLE PARK, N.C., June  15, 2026  (GLOBE NEWSWIRE) -- Fennec Pharmaceuticals Inc. (NASDAQ:FENC) (TSX:FRX) (“Fennec” or the “Company”), a specialty pharmaceutical company, today announced that on June 10, 2026, the Compensation Committee of the Company’s Board of Directors approved the grant of incentive stock option awards (“ISOs”) to purchase an aggregate of 10,000 of the Company’s common shares to one new non-executive employee of the Company with a grant date of June 15, 2026 under the Company’s 2026 Equity Inducement Plan (the “Inducement Plan”). The ISOs were granted as inducements material to the employee entering into</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/Fennec+Pharmaceuticals+Announces+Inducement+Grants+Under+Nasdaq+Listing+Rule+5635%28C%29%284%29/26643470.html</guid>
   <pubDate>Mon, 15 Jun 2026 06:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">FENC</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">FRX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.21047090</category>
   	  </item>
  <item>
   <title>Form  S-8        FENNEC PHARMACEUTICALS               </title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++S-8++++++++FENNEC+PHARMACEUTICALS+++++++++++++++/26636704.html</link>
   <description>si-local-file:///var/storage/secattach/20260611/26636704.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++S-8++++++++FENNEC+PHARMACEUTICALS+++++++++++++++/26636704.html</guid>
   <pubDate>Thu, 11 Jun 2026 17:07:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">FENC</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.21047090</category>
   	  </item>
  <item>
   <title>Form  S-8        FENNEC PHARMACEUTICALS               </title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++S-8++++++++FENNEC+PHARMACEUTICALS+++++++++++++++/26636704.html</link>
   <description>si-local-file:///var/storage/secattach/20260611/26636704.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++S-8++++++++FENNEC+PHARMACEUTICALS+++++++++++++++/26636704.html</guid>
   <pubDate>Thu, 11 Jun 2026 17:07:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">FENC</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.21047090</category>
   	  </item>
  <item>
   <title>Form  4          FENNEC PHARMACEUTICALS    For: Jun 10  Filed by: Brughera Marco Maria</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++FENNEC+PHARMACEUTICALS++++For%3A+Jun+10++Filed+by%3A+Brughera+Marco+Maria/26631057.html</link>
   <description>si-local-file:///var/storage/secattach/20260610/26631057.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++FENNEC+PHARMACEUTICALS++++For%3A+Jun+10++Filed+by%3A+Brughera+Marco+Maria/26631057.html</guid>
   <pubDate>Wed, 10 Jun 2026 17:51:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">FENC</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.21047090</category>
   	  </item>
  <item>
   <title>Form  4          FENNEC PHARMACEUTICALS    For: Jun 10  Filed by: Brughera Marco Maria</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++FENNEC+PHARMACEUTICALS++++For%3A+Jun+10++Filed+by%3A+Brughera+Marco+Maria/26631057.html</link>
   <description>si-local-file:///var/storage/secattach/20260610/26631057.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++FENNEC+PHARMACEUTICALS++++For%3A+Jun+10++Filed+by%3A+Brughera+Marco+Maria/26631057.html</guid>
   <pubDate>Wed, 10 Jun 2026 17:51:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">FENC</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.21047090</category>
   	  </item>
  <item>
   <title>Form  4          FENNEC PHARMACEUTICALS    For: Jun 10  Filed by: Islam Khalid</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++FENNEC+PHARMACEUTICALS++++For%3A+Jun+10++Filed+by%3A+Islam+Khalid/26630970.html</link>
   <description>si-local-file:///var/storage/secattach/20260610/26630970.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++FENNEC+PHARMACEUTICALS++++For%3A+Jun+10++Filed+by%3A+Islam+Khalid/26630970.html</guid>
   <pubDate>Wed, 10 Jun 2026 17:27:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">FENC</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.21047090</category>
   	  </item>
  <item>
   <title>Form  4          FENNEC PHARMACEUTICALS    For: Jun 10  Filed by: Islam Khalid</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++FENNEC+PHARMACEUTICALS++++For%3A+Jun+10++Filed+by%3A+Islam+Khalid/26630970.html</link>
   <description>si-local-file:///var/storage/secattach/20260610/26630970.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++FENNEC+PHARMACEUTICALS++++For%3A+Jun+10++Filed+by%3A+Islam+Khalid/26630970.html</guid>
   <pubDate>Wed, 10 Jun 2026 17:27:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">FENC</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.21047090</category>
   	  </item>
  <item>
   <title>Form  4          FENNEC PHARMACEUTICALS    For: Jun 10  Filed by: Cook Jodi A</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++FENNEC+PHARMACEUTICALS++++For%3A+Jun+10++Filed+by%3A+Cook+Jodi+A/26630982.html</link>
   <description>si-local-file:///var/storage/secattach/20260610/26630982.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++FENNEC+PHARMACEUTICALS++++For%3A+Jun+10++Filed+by%3A+Cook+Jodi+A/26630982.html</guid>
   <pubDate>Wed, 10 Jun 2026 17:27:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">FENC</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.21047090</category>
   	  </item>
  <item>
   <title>Form  4          FENNEC PHARMACEUTICALS    For: Jun 10  Filed by: Cook Jodi A</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++FENNEC+PHARMACEUTICALS++++For%3A+Jun+10++Filed+by%3A+Cook+Jodi+A/26630982.html</link>
   <description>si-local-file:///var/storage/secattach/20260610/26630982.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++FENNEC+PHARMACEUTICALS++++For%3A+Jun+10++Filed+by%3A+Cook+Jodi+A/26630982.html</guid>
   <pubDate>Wed, 10 Jun 2026 17:27:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">FENC</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.21047090</category>
   	  </item>
  <item>
   <title>Form  4          FENNEC PHARMACEUTICALS    For: Jun 10  Filed by: RALLIS CHRIS A</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++FENNEC+PHARMACEUTICALS++++For%3A+Jun+10++Filed+by%3A+RALLIS+CHRIS+A/26630953.html</link>
   <description>si-local-file:///var/storage/secattach/20260610/26630953.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++FENNEC+PHARMACEUTICALS++++For%3A+Jun+10++Filed+by%3A+RALLIS+CHRIS+A/26630953.html</guid>
   <pubDate>Wed, 10 Jun 2026 17:25:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">FENC</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.21047090</category>
   	  </item>
  <item>
   <title>Form  4          FENNEC PHARMACEUTICALS    For: Jun 10  Filed by: RALLIS CHRIS A</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++FENNEC+PHARMACEUTICALS++++For%3A+Jun+10++Filed+by%3A+RALLIS+CHRIS+A/26630953.html</link>
   <description>si-local-file:///var/storage/secattach/20260610/26630953.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++FENNEC+PHARMACEUTICALS++++For%3A+Jun+10++Filed+by%3A+RALLIS+CHRIS+A/26630953.html</guid>
   <pubDate>Wed, 10 Jun 2026 17:25:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">FENC</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.21047090</category>
   	  </item>
  <item>
   <title>Form  8-K        FENNEC PHARMACEUTICALS    For: Jun 10</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++FENNEC+PHARMACEUTICALS++++For%3A+Jun+10/26630904.html</link>
   <description>si-local-file:///var/storage/secattach/20260610/26630904.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++FENNEC+PHARMACEUTICALS++++For%3A+Jun+10/26630904.html</guid>
   <pubDate>Wed, 10 Jun 2026 17:19:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">FENC</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.21047090</category>
   	  </item>
  <item>
   <title>Form  8-K        FENNEC PHARMACEUTICALS    For: Jun 10</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++FENNEC+PHARMACEUTICALS++++For%3A+Jun+10/26630904.html</link>
   <description>si-local-file:///var/storage/secattach/20260610/26630904.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++FENNEC+PHARMACEUTICALS++++For%3A+Jun+10/26630904.html</guid>
   <pubDate>Wed, 10 Jun 2026 17:19:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">FENC</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.21047090</category>
   	  </item>
  <item>
   <title>Fennec Announces Results of Annual Meeting</title>
   <link>http://www.streetinsider.com/Press+Releases/Fennec+Announces+Results+of+Annual+Meeting/26630301.html</link>
   <description>
&lt;p align=&quot;justify&quot;&gt;RESEARCH TRIANGLE PARK, N.C., June  10, 2026  (GLOBE NEWSWIRE) -- Fennec Pharmaceuticals Inc. (the “Company”) (NASDAQ:FENC) (TSX:FRX) today announced that the nominees listed in the management proxy circular dated April 28, 2026 were elected as directors of the Company at the Annual General and Special Meeting of Shareholders held online on June 10, 2025.&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;Detailed results of the vote for the election of directors are set out below:&lt;/p&gt; &lt;table style=&quot;border-top: solid black 1pt ; border-right: solid black 1pt ; border-bottom: solid black 1pt ; border-left: solid black 1pt ; border-collapse: collapse; width:100%; border-collapse:collapse ;&quot;&gt;&lt;tr&gt;&lt;td style=&quot;border-top:</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Fennec+Announces+Results+of+Annual+Meeting/26630301.html</guid>
   <pubDate>Wed, 10 Jun 2026 16:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">FENC</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">FRX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.21047090</category>
   	  </item>
  <item>
   <title>Fennec Announces Results of Annual Meeting</title>
   <link>http://www.streetinsider.com/Press+Releases/Fennec+Announces+Results+of+Annual+Meeting/26630301.html</link>
   <description>
&lt;p align=&quot;justify&quot;&gt;RESEARCH TRIANGLE PARK, N.C., June  10, 2026  (GLOBE NEWSWIRE) -- Fennec Pharmaceuticals Inc. (the “Company”) (NASDAQ:FENC) (TSX:FRX) today announced that the nominees listed in the management proxy circular dated April 28, 2026 were elected as directors of the Company at the Annual General and Special Meeting of Shareholders held online on June 10, 2025.&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;Detailed results of the vote for the election of directors are set out below:&lt;/p&gt; &lt;table style=&quot;border-top: solid black 1pt ; border-right: solid black 1pt ; border-bottom: solid black 1pt ; border-left: solid black 1pt ; border-collapse: collapse; width:100%; border-collapse:collapse ;&quot;&gt;&lt;tr&gt;&lt;td style=&quot;border-top:</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Fennec+Announces+Results+of+Annual+Meeting/26630301.html</guid>
   <pubDate>Wed, 10 Jun 2026 16:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">FENC</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">FRX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.21047090</category>
   	  </item>
  <item>
   <title>Fennec Announces Results of Annual Meeting</title>
   <link>http://www.streetinsider.com/Press+Releases/Fennec+Announces+Results+of+Annual+Meeting/26630301.html</link>
   <description>
&lt;p align=&quot;justify&quot;&gt;RESEARCH TRIANGLE PARK, N.C., June  10, 2026  (GLOBE NEWSWIRE) -- Fennec Pharmaceuticals Inc. (the “Company”) (NASDAQ:FENC) (TSX:FRX) today announced that the nominees listed in the management proxy circular dated April 28, 2026 were elected as directors of the Company at the Annual General and Special Meeting of Shareholders held online on June 10, 2025.&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;Detailed results of the vote for the election of directors are set out below:&lt;/p&gt; &lt;table style=&quot;border-top: solid black 1pt ; border-right: solid black 1pt ; border-bottom: solid black 1pt ; border-left: solid black 1pt ; border-collapse: collapse; width:100%; border-collapse:collapse ;&quot;&gt;&lt;tr&gt;&lt;td style=&quot;border-top:</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Fennec+Announces+Results+of+Annual+Meeting/26630301.html</guid>
   <pubDate>Wed, 10 Jun 2026 16:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">FENC</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">FRX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.21047090</category>
   	  </item>
  <item>
   <title>Fennec Announces Results of Annual Meeting</title>
   <link>http://www.streetinsider.com/Globe+Newswire/Fennec+Announces+Results+of+Annual+Meeting/26630301.html</link>
   <description>
&lt;p align=&quot;justify&quot;&gt;RESEARCH TRIANGLE PARK, N.C., June  10, 2026  (GLOBE NEWSWIRE) -- Fennec Pharmaceuticals Inc. (the “Company”) (NASDAQ:FENC) (TSX:FRX) today announced that the nominees listed in the management proxy circular dated April 28, 2026 were elected as directors of the Company at the Annual General and Special Meeting of Shareholders held online on June 10, 2025.&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;Detailed results of the vote for the election of directors are set out below:&lt;/p&gt; &lt;table style=&quot;border-top: solid black 1pt ; border-right: solid black 1pt ; border-bottom: solid black 1pt ; border-left: solid black 1pt ; border-collapse: collapse; width:100%; border-collapse:collapse ;&quot;&gt;&lt;tr&gt;&lt;td style=&quot;border-top:</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/Fennec+Announces+Results+of+Annual+Meeting/26630301.html</guid>
   <pubDate>Wed, 10 Jun 2026 16:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">FENC</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">FRX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.21047090</category>
   	  </item>
  <item>
   <title>Fennec Announces Results of Annual Meeting</title>
   <link>http://www.streetinsider.com/Globe+Newswire/Fennec+Announces+Results+of+Annual+Meeting/26630301.html</link>
   <description>
&lt;p align=&quot;justify&quot;&gt;RESEARCH TRIANGLE PARK, N.C., June  10, 2026  (GLOBE NEWSWIRE) -- Fennec Pharmaceuticals Inc. (the “Company”) (NASDAQ:FENC) (TSX:FRX) today announced that the nominees listed in the management proxy circular dated April 28, 2026 were elected as directors of the Company at the Annual General and Special Meeting of Shareholders held online on June 10, 2025.&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;Detailed results of the vote for the election of directors are set out below:&lt;/p&gt; &lt;table style=&quot;border-top: solid black 1pt ; border-right: solid black 1pt ; border-bottom: solid black 1pt ; border-left: solid black 1pt ; border-collapse: collapse; width:100%; border-collapse:collapse ;&quot;&gt;&lt;tr&gt;&lt;td style=&quot;border-top:</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/Fennec+Announces+Results+of+Annual+Meeting/26630301.html</guid>
   <pubDate>Wed, 10 Jun 2026 16:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">FENC</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">FRX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.21047090</category>
   	  </item>
  <item>
   <title>Fennec Announces Results of Annual Meeting</title>
   <link>http://www.streetinsider.com/Globe+Newswire/Fennec+Announces+Results+of+Annual+Meeting/26630301.html</link>
   <description>
&lt;p align=&quot;justify&quot;&gt;RESEARCH TRIANGLE PARK, N.C., June  10, 2026  (GLOBE NEWSWIRE) -- Fennec Pharmaceuticals Inc. (the “Company”) (NASDAQ:FENC) (TSX:FRX) today announced that the nominees listed in the management proxy circular dated April 28, 2026 were elected as directors of the Company at the Annual General and Special Meeting of Shareholders held online on June 10, 2025.&lt;/p&gt;  &lt;p align=&quot;justify&quot;&gt;Detailed results of the vote for the election of directors are set out below:&lt;/p&gt; &lt;table style=&quot;border-top: solid black 1pt ; border-right: solid black 1pt ; border-bottom: solid black 1pt ; border-left: solid black 1pt ; border-collapse: collapse; width:100%; border-collapse:collapse ;&quot;&gt;&lt;tr&gt;&lt;td style=&quot;border-top:</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/Fennec+Announces+Results+of+Annual+Meeting/26630301.html</guid>
   <pubDate>Wed, 10 Jun 2026 16:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">FENC</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">FRX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.21047090</category>
   	  </item>
  <item>
   <title>Form  4          FENNEC PHARMACEUTICALS    For: May 31  Filed by: Raykov Rosty</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++FENNEC+PHARMACEUTICALS++++For%3A+May+31++Filed+by%3A+Raykov+Rosty/26591575.html</link>
   <description>si-local-file:///var/storage/secattach/20260602/26591575.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++FENNEC+PHARMACEUTICALS++++For%3A+May+31++Filed+by%3A+Raykov+Rosty/26591575.html</guid>
   <pubDate>Tue, 02 Jun 2026 16:06:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">FENC</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.21047090</category>
   	  </item>
 </channel>
</rss>
